{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:47:59Z","timestamp":1778154479430,"version":"3.51.4"},"reference-count":148,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.clp.2019.02.009","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T04:53:04Z","timestamp":1553748784000},"page":"235-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Treatment of Viral Infections During Pregnancy"],"prefix":"10.1016","volume":"46","author":[{"given":"Sarah C.","family":"Rogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard H.","family":"Beigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clp.2019.02.009_bib1","doi-asserted-by":"crossref","first-page":"e114989","DOI":"10.1371\/journal.pone.0114989","article-title":"Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012","volume":"10","author":"Looker","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.clp.2019.02.009_bib2","doi-asserted-by":"crossref","first-page":"e0140765","DOI":"10.1371\/journal.pone.0140765","article-title":"Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012","volume":"10","author":"Looker","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clp.2019.02.009_bib3","series-title":"Prevalence of herpes simplex virus type 1 and type 2 in persons aged 14-49: United States, 2015-2016. NCHS data brief, no 304","author":"Mcquillan","year":"2018"},{"issue":"8","key":"10.1016\/j.clp.2019.02.009_bib4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199708213370801","article-title":"The acquisition of herpes simplex virus during pregnancy","volume":"337","author":"Brown","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.clp.2019.02.009_bib5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/cid\/cis891","article-title":"Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women","volume":"56","author":"Bernstein","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.clp.2019.02.009_bib6","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1056\/NEJM199105023241804","article-title":"Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor","volume":"324","author":"Brown","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"RR-03","key":"10.1016\/j.clp.2019.02.009_bib7","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"10.1016\/j.clp.2019.02.009_bib8","first-page":"1489","article-title":"ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. no. 82 June 2007. Management of herpes in pregnancy","volume":"109","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.clp.2019.02.009_bib9","first-page":"1396","article-title":"Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review","volume":"102","author":"Sheffield","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.clp.2019.02.009_bib10","article-title":"Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection","author":"Hollier","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.clp.2019.02.009_bib11","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1067\/mob.2003.185","article-title":"A\u00a0double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery","volume":"188","author":"Watts","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.clp.2019.02.009_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpeds.2011.12.053","article-title":"Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: a multicenter case series","volume":"161","author":"Pinninti","year":"2012","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.clp.2019.02.009_bib13","first-page":"102","article-title":"Oral acyclovir and recurrent genital herpes during late pregnancy","volume":"82","author":"Haddad","year":"1993","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.clp.2019.02.009_bib14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0002-9378(11)80023-2","article-title":"Pharmacokinetics of acyclovir in the term human pregnancy and neonate","volume":"164","author":"Frenkel","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib15","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0002-9378(98)70176-0","article-title":"Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy","volume":"179","author":"Kimberlin","year":"1998","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.clp.2019.02.009_bib16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/jama.2010.1206","article-title":"Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects","volume":"304","author":"Pasternak","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/bdra.20013","article-title":"Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984-1999","volume":"70","author":"Stone","year":"2004","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"9","key":"10.1016\/j.clp.2019.02.009_bib18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the United States, 1988-1994","volume":"43","author":"Staras","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.clp.2019.02.009_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/rmv.659","article-title":"Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV","volume":"20","author":"Hyde","year":"2010","journal-title":"Rev Med Virol"},{"issue":"5","key":"10.1016\/j.clp.2019.02.009_bib20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev Med Virol"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib21","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1086\/600882","article-title":"Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population","volume":"49","author":"Mussi-Pinhata","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"issue":"2","key":"10.1016\/j.clp.2019.02.009_bib23","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1093\/cid\/ciq085","article-title":"Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection","volume":"52","author":"Wang","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00431-002-1115-5","article-title":"Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature","volume":"162","author":"Gaytant","year":"2003","journal-title":"Eur J Pediatr"},{"issue":"8","key":"10.1016\/j.clp.2019.02.009_bib25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/pd.4118","article-title":"A\u00a0series of 238 cytomegalovirus primary infections during pregnancy: description and outcome","volume":"33","author":"Picone","year":"2013","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.clp.2019.02.009_bib26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcv.2011.07.005","article-title":"Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age","volume":"52","author":"Enders","year":"2011","journal-title":"J\u00a0Clin Virol"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib27","doi-asserted-by":"crossref","first-page":"380.e1-7","DOI":"10.1016\/j.ajog.2007.09.052","article-title":"Ultrasound prediction of symptomatic congenital cytomegalovirus infection","volume":"198","author":"Guerra","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.clp.2019.02.009_bib28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/pd.4340","article-title":"Detailed in utero ultrasound description of 30 cases of congenital cytomegalovirus infection","volume":"34","author":"Picone","year":"2014","journal-title":"Prenat Diagn"},{"issue":"20","key":"10.1016\/j.clp.2019.02.009_bib29","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJM198511143132006","article-title":"Herpesvirus infections of pregnancy","volume":"313","author":"Stagno","year":"1985","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.clp.2019.02.009_bib30","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199203053261003","article-title":"The outcome of congenital cytomegalovirus infection in relation to maternal antibody status","volume":"326","author":"Fowler","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.clp.2019.02.009_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcv.2007.09.004","article-title":"Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment","volume":"41","author":"Grosse","year":"2008","journal-title":"J\u00a0Clin Virol"},{"issue":"13","key":"10.1016\/j.clp.2019.02.009_bib32","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJMoa043337","article-title":"Passive immunization during pregnancy for congenital cytomegalovirus infection","volume":"353","author":"Nigro","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cid\/cis423","article-title":"Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age","volume":"55","author":"Visentin","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.clp.2019.02.009_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/infdis\/jir718","article-title":"Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy--a case-control study of the outcome in children","volume":"205","author":"Nigro","year":"2012","journal-title":"J\u00a0Infect Dis"},{"issue":"14","key":"10.1016\/j.clp.2019.02.009_bib35","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","article-title":"A\u00a0randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus","volume":"370","author":"Revello","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.clp.2019.02.009_bib36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/14767058.2014.907265","article-title":"Primary maternal cytomegalovirus infections during pregnancy: association of CMV hyperimmune globulin with gestational age at birth and birth weight","volume":"28","author":"Nigro","year":"2015","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"6","key":"10.1016\/j.clp.2019.02.009_bib37","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00404-018-4703-y","article-title":"No evidence of obstetrical adverse events after hyperimmune globulin application for primary cytomegalovirus infection in pregnancy: experience from a single centre","volume":"297","author":"Chiaie","year":"2018","journal-title":"Arch Gynecol Obstet"},{"issue":"11","key":"10.1016\/j.clp.2019.02.009_bib38","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jogc.2018.03.013","article-title":"Use of cytomegalovirus-specific hyperimmunoglobulins in pregnancy: a retrospective cohort","volume":"40","author":"Minsart","year":"2018","journal-title":"J\u00a0Obstet Gynaecol Can"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/14767058.2017.1387890","article-title":"Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid","volume":"32","author":"Bl\u00e1zquez-Gamero","year":"2019","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"9","key":"10.1016\/j.clp.2019.02.009_bib40","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1471-0528.2007.01308.x","article-title":"Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection","volume":"114","author":"Jacquemard","year":"2007","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib41","doi-asserted-by":"crossref","first-page":"462.e1","DOI":"10.1016\/j.ajog.2016.04.003","article-title":"In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study","volume":"215","author":"Leruez-Ville","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.clp.2019.02.009_bib42","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1097\/01.AOG.0000466430.19823.53","article-title":"ACOG practice bulletin no. 151: cytomegalovirus, parvovirus B12, varicella zoster, and toxoplasmosis in pregnancy","volume":"125","author":"American College of Obstetricians and Gynecologists","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.clp.2019.02.009_bib43","doi-asserted-by":"crossref","first-page":"B5","DOI":"10.1016\/j.ajog.2016.02.042","article-title":"Diagnosis and antenatal management of congenital cytomegalovirus infection","volume":"214","author":"Hughes","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.clp.2019.02.009_bib44","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","article-title":"Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy","volume":"17","author":"Rawlinson","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clp.2019.02.009_bib45","series-title":"Global hepatitis report 2017","year":"2017"},{"key":"10.1016\/j.clp.2019.02.009_bib46","series-title":"Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection","year":"2015"},{"issue":"1","key":"10.1016\/j.clp.2019.02.009_bib47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajog.2015.09.100","article-title":"#38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission","volume":"214","author":"Dionne-Odom","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib48","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/01.AOG.0000263930.28382.2a","article-title":"ACOG practice bulletin no. 86: viral hepatitis in pregnancy","volume":"110","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"RR-16","key":"10.1016\/j.clp.2019.02.009_bib49","first-page":"1","article-title":"A\u00a0comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices (ACIP) part 1: immunization of infants, children, and adolescents","volume":"54","author":"Mast","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"10.1016\/j.clp.2019.02.009_bib50","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/infdis\/170.6.1418","article-title":"Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load","volume":"170","author":"Burk","year":"1994","journal-title":"J\u00a0Infect Dis"},{"issue":"15","key":"10.1016\/j.clp.2019.02.009_bib51","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0264-410X(97)00080-7","article-title":"Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity","volume":"15","author":"del Canho","year":"1997","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.clp.2019.02.009_bib52","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5694\/j.1326-5377.2009.tb02524.x","article-title":"Perinatal transmission of hepatitis B virus: an Australian experience","volume":"190","author":"Wiseman","year":"2009","journal-title":"Med J Aust"},{"issue":"9","key":"10.1016\/j.clp.2019.02.009_bib53","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/INF.0000000000000315","article-title":"Immunoprophylaxis failure against vertical transmission of hepatitis B virus in the Chinese population","volume":"33","author":"Lin","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.clp.2019.02.009_bib54","doi-asserted-by":"crossref","first-page":"828","DOI":"10.7326\/M13-2529","article-title":"Prevention of vertical transmission of hepatitis B","volume":"160","author":"Kubo","year":"2014","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.clp.2019.02.009_bib55","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.cgh.2011.10.041","article-title":"An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus","volume":"10","author":"Pan","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clp.2019.02.009_bib56","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/j.1365-2893.2011.01492.x","article-title":"Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers","volume":"19","author":"Zou","year":"2012","journal-title":"J\u00a0Viral Hepat"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib57","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clp.2019.02.009_bib58","article-title":"Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus","author":"Eke","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.clp.2019.02.009_bib59","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2893.2006.00738.x","article-title":"Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study","volume":"13","author":"Yuan","year":"2006","journal-title":"J\u00a0Viral Hepat"},{"issue":"5","key":"10.1016\/j.clp.2019.02.009_bib60","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jhep.2012.06.031","article-title":"Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the antiretroviral pregnancy registry","volume":"57","author":"Brown","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"38","key":"10.1016\/j.clp.2019.02.009_bib61","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.3748\/wjg.v17.i38.4321","article-title":"A\u00a0meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus","volume":"17","author":"Han","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.clp.2019.02.009_bib62","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/AOG.0b013e3181e45951","article-title":"Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus","volume":"116","author":"Shi","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.clp.2019.02.009_bib63","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2014.04.038","article-title":"Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus","volume":"61","author":"Greenup","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.clp.2019.02.009_bib64","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/hep.27837","article-title":"Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus","volume":"62","author":"Chen","year":"2015","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.clp.2019.02.009_bib65","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","article-title":"Tenofovir to Prevent hepatitis B transmission in mothers with high viral load","volume":"374","author":"Pan","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.clp.2019.02.009_bib66","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1708131","article-title":"Tenofovir versus placebo to prevent perinatal transmission of hepatitis B","volume":"378","author":"Jourdain","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.clp.2019.02.009_bib67","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1056\/NEJMc1805396","article-title":"Tenofovir to prevent perinatal transmission of hepatitis B","volume":"378","author":"Terrault","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.clp.2019.02.009_bib68","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJMe1801662","article-title":"A\u00a0shift in thinking to reduce mother-to-infant transmission of hepatitis B","volume":"378","author":"Dusheiko","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.clp.2019.02.009_bib69","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12962-018-0088-9","article-title":"Cost-effectiveness of antiviral prophylaxis during pregnancy for the prevention of perinatal hepatitis B infection in South Korea","volume":"16","author":"Lee","year":"2018","journal-title":"Cost Eff Resour Alloc"},{"issue":"3","key":"10.1016\/j.clp.2019.02.009_bib70","doi-asserted-by":"crossref","first-page":"231.e1-7","DOI":"10.1016\/j.ajog.2012.06.001","article-title":"Antenatal lamivudine to reduce perinatal hepatitis B transmission: a cost-effectiveness analysis","volume":"207","author":"Nayeri","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.clp.2019.02.009_bib71","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clp.2019.02.009_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.clp.2019.02.009_bib73","series-title":"ACOG practice advisory: hepatitis B prevention","year":"2018"},{"issue":"3","key":"10.1016\/j.clp.2019.02.009_bib74","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.510310328","article-title":"Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women","volume":"31","author":"Conte","year":"2000","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clp.2019.02.009_bib75","doi-asserted-by":"crossref","first-page":"38.e1-9","DOI":"10.1016\/j.ajog.2008.03.052","article-title":"Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort","volume":"199","author":"Pergam","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.clp.2019.02.009_bib76","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1111\/j.1365-2893.2011.01436.x","article-title":"Pregnancy outcomes associated with viral hepatitis","volume":"18","author":"Reddick","year":"2011","journal-title":"J\u00a0Viral Hepat"},{"issue":"35","key":"10.1016\/j.clp.2019.02.009_bib77","doi-asserted-by":"crossref","first-page":"e4777","DOI":"10.1097\/MD.0000000000004777","article-title":"Maternal HCV infection is associated with intrauterine fetal growth disturbance: a meta-analysis of observational studies","volume":"95","author":"Huang","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.clp.2019.02.009_bib78","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1478-3231.2011.02556.x","article-title":"Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes","volume":"31","author":"Connell","year":"2011","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.clp.2019.02.009_bib79","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clinre.2016.07.004","article-title":"Hepatitis C infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis","volume":"41","author":"Wijarnpreecha","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"6","key":"10.1016\/j.clp.2019.02.009_bib80","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","article-title":"Vertical transmission of hepatitis C virus: systematic review and meta-analysis","volume":"59","author":"Benova","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"7156","key":"10.1016\/j.clp.2019.02.009_bib81","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/bmj.317.7156.437","article-title":"Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany study group on hepatitis C virus infection","volume":"317","author":"Resti","year":"1998","journal-title":"BMJ"},{"issue":"8945","key":"10.1016\/j.clp.2019.02.009_bib82","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0140-6736(95)90277-5","article-title":"Mother-to-infant transmission of hepatitis C virus","volume":"345","author":"Zanetti","year":"1995","journal-title":"Lancet"},{"issue":"9233","key":"10.1016\/j.clp.2019.02.009_bib83","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(00)02681-7","article-title":"Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission","volume":"356","author":"Gibb","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.clp.2019.02.009_bib84","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/jhep.2001.25885","article-title":"Mother-to-infant transmission of hepatitis C virus","volume":"34","author":"Yeung","year":"2001","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clp.2019.02.009_bib85","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2017.07.039","article-title":"Hepatitis C in pregnancy: screening, treatment, and management","volume":"217","author":"Hughes","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.009_bib86","author":"AASLD-IDSA"},{"key":"10.1016\/j.clp.2019.02.009_bib87","series-title":"Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection","year":"2018"},{"issue":"3","key":"10.1016\/j.clp.2019.02.009_bib88","first-page":"154","article-title":"Direct-acting antiviral medications for chronic hepatitis C virus infection","volume":"7","author":"Jazwinski","year":"2011","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"2","key":"10.1016\/j.clp.2019.02.009_bib89","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11904-018-0386-z","article-title":"Treatment of hepatitis C during pregnancy-weighing the risks and benefits in contrast to HIV","volume":"15","author":"Barritt","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.clp.2019.02.009_bib90","volume":"vol. 29","year":"2018"},{"issue":"3","key":"10.1016\/j.clp.2019.02.009_bib91","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/QAI.0b013e3182167dec","article-title":"Estimated number of infants born to HIV-infected women in the United States and five dependent areas, 2006","volume":"57","author":"Whitmore","year":"2011","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"18","key":"10.1016\/j.clp.2019.02.009_bib92","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment","volume":"331","author":"Connor","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.clp.2019.02.009_bib93","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00042560-200204150-00009","article-title":"Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission","volume":"29","author":"Cooper","year":"2002","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.clp.2019.02.009_bib94","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/QAD.0b013e328350995c","article-title":"A\u00a0national review of vertical HIV transmission","volume":"26","author":"Forbes","year":"2012","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.clp.2019.02.009_bib95","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/cid\/civ578","article-title":"No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception","volume":"61","author":"Mandelbrot","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.clp.2019.02.009_bib97","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM199908053410601","article-title":"Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine","volume":"341","author":"Mofenson","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.clp.2019.02.009_bib98","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/QAD.0000000000000212","article-title":"Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011","volume":"28","author":"Townsend","year":"2014","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.clp.2019.02.009_bib99","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/QAI.0b013e3181cf9979","article-title":"Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa","volume":"54","author":"Hoffman","year":"2010","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"7","key":"10.1016\/j.clp.2019.02.009_bib100","article-title":"Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection","author":"Siegfried","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"18","key":"10.1016\/j.clp.2019.02.009_bib101","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1511691","article-title":"Benefits and risks of antiretroviral therapy for perinatal HIV prevention","volume":"375","author":"Fowler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.clp.2019.02.009_bib102","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/cid\/cit374","article-title":"Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?","volume":"57","author":"Briand","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib103","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1086\/650005","article-title":"Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 Copies\/mL at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1)","volume":"50","author":"Tubiana","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib104","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/QAD.0b013e32801424bd","article-title":"Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding","volume":"21","author":"Graham","year":"2007","journal-title":"AIDS"},{"issue":"15","key":"10.1016\/j.clp.2019.02.009_bib105","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/00002030-200310170-00004","article-title":"Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies","volume":"17","author":"Fiore","year":"2003","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.clp.2019.02.009_bib106","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/infdis\/jix550","article-title":"Prevalence, magnitude, and correlates of HIV-1 genital shedding in women on antiretroviral therapy","volume":"216","author":"King","year":"2017","journal-title":"J\u00a0Infect Dis"},{"issue":"16","key":"10.1016\/j.clp.2019.02.009_bib107","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1097\/QAD.0b013e32833e5043","article-title":"Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load","volume":"24","author":"Cu-Uvin","year":"2010","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.clp.2019.02.009_bib108","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3851\/IMP1856","article-title":"Residual HIV-1 RNA and HIV-1 DNA production in the genital tract reservoir of women treated with HAART: the prospective ANRS EP24 GYNODYN study","volume":"16","author":"Launay","year":"2011","journal-title":"Antivir Ther"},{"issue":"2","key":"10.1016\/j.clp.2019.02.009_bib109","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1086\/317918","article-title":"Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections","volume":"183","author":"John","year":"2001","journal-title":"J\u00a0Infect Dis"},{"issue":"11","key":"10.1016\/j.clp.2019.02.009_bib110","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s40262-014-0185-7","article-title":"Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals","volume":"53","author":"McCormack","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clp.2019.02.009_bib111","series-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach","year":"2016"},{"key":"10.1016\/j.clp.2019.02.009_bib112","series-title":"Antiretroviral pregnancy registry interim report for 1 January 1989 through 31 January 2018","year":"2017"},{"issue":"10","key":"10.1016\/j.clp.2019.02.009_bib113","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1056\/NEJMc1807653","article-title":"Neural-tube defects with dolutegravir treatment from the time of conception","volume":"379","author":"Zash","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.clp.2019.02.009_bib114","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/INF.0b013e318235c7aa","article-title":"Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals","volume":"31","author":"Knapp","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.clp.2019.02.009_bib115","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/INF.0b013e3181e74a2f","article-title":"Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C","volume":"29","author":"Brogly","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.clp.2019.02.009_bib116","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jamapediatrics.2014.1889","article-title":"Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants","volume":"169","author":"Williams","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib117","doi-asserted-by":"crossref","first-page":"e1001635","DOI":"10.1371\/journal.pmed.1001635","article-title":"Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1\/CO11)","volume":"11","author":"Sibiude","year":"2014","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.clp.2019.02.009_bib118","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/cid\/civ260","article-title":"In Utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial","volume":"61","author":"Sibiude","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.clp.2019.02.009_bib119","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1471-0528.2010.02689.x","article-title":"Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe","volume":"117","author":"Townsend","year":"2010","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.clp.2019.02.009_bib120","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/QAD.0b013e32802ef2f6","article-title":"Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis","volume":"21","author":"Kourtis","year":"2007","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.clp.2019.02.009_bib121","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2352-3018(15)00207-6","article-title":"Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis","volume":"3","author":"Wedi","year":"2016","journal-title":"Lancet HIV"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib122","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/QAI.0000000000001253","article-title":"PMTCT option B+ does not increase preterm birth risk and may prevent extreme prematurity: a retrospective cohort study in Malawi","volume":"74","author":"Chagomerana","year":"2017","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib123","doi-asserted-by":"crossref","first-page":"e900","DOI":"10.1542\/peds.2006-1123","article-title":"Pediatric spectrum of HIV disease consortium. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: pediatric spectrum of HIV disease, 1989-2004","volume":"119","author":"Schulte","year":"2007","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.clp.2019.02.009_bib124","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1086\/503045","article-title":"Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?","volume":"193","author":"Cotter","year":"2006","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib125","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/infdis\/jir307","article-title":"Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy","volume":"204","author":"Powis","year":"2011","journal-title":"J\u00a0Infect Dis"},{"issue":"14","key":"10.1016\/j.clp.2019.02.009_bib126","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/QAD.0b013e32830b8ab9","article-title":"Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, C\u00f4te d\u2019Ivoire","volume":"22","author":"Ekouevi","year":"2008","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.clp.2019.02.009_bib127","doi-asserted-by":"crossref","first-page":"e0150565","DOI":"10.1371\/journal.pone.0150565","article-title":"Preterm birth and low birth weight after in utero exposure to antiretrovirals initiated during pregnancy in yaound\u00e9, Cameroon","volume":"11","author":"Njom Nlend","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.clp.2019.02.009_bib128","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/QAD.0b013e32832be0df","article-title":"No relation between in-utero exposure to HAART and intrauterine growth retardation","volume":"23","author":"Briand","year":"2009","journal-title":"AIDS"},{"issue":"24","key":"10.1016\/j.clp.2019.02.009_bib129","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa991159","article-title":"Antiretroviral therapy during pregnancy and the risk of an adverse outcome","volume":"346","author":"Tuomala","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.clp.2019.02.009_bib130","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1097\/01.aids.0000253362.01696.9d","article-title":"Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth","volume":"20","author":"Szyld","year":"2006","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.clp.2019.02.009_bib131","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1086\/420834","article-title":"Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis","volume":"189","author":"Read","year":"2004","journal-title":"J\u00a0Infect Dis"},{"issue":"11","key":"10.1016\/j.clp.2019.02.009_bib132","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/cid\/cix1102","article-title":"Contribution of maternal antiretroviral therapy and breastfeeding to 24-month survival in human immunodeficiency virus-exposed uninfected children: an individual pooled analysis of African and Asian studies","volume":"66","author":"Arikawa","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.clp.2019.02.009_bib133","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1086\/374273","article-title":"Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease","volume":"187","author":"Rousseau","year":"2003","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib134","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/QAI.0000000000001612","article-title":"Prevention of HIV-1 transmission through breastfeeding","volume":"77","author":"Flynn","year":"2018","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"24","key":"10.1016\/j.clp.2019.02.009_bib135","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa0911486","article-title":"Maternal or infant antiretroviral drugs to reduce HIV-1 transmission","volume":"362","author":"Chasela","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.clp.2019.02.009_bib136","article-title":"Antiretroviral interventions for preventing breast milk transmission of HIV","author":"White","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.clp.2019.02.009_bib137","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/INF.0b013e3181950c56","article-title":"Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding","volume":"28","author":"Marazzi","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib138","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/cid\/cix820","volume":"66","author":"Dinh","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.clp.2019.02.009_bib139","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1473-3099(10)70288-7","article-title":"Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial","volume":"11","author":"de Vincenzi","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.clp.2019.02.009_bib140","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/jac\/dkv080","article-title":"Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies","volume":"70","author":"Waitt","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib141","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/jac\/dkx507","article-title":"Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother-infant pairs","volume":"73","author":"Waitt","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.clp.2019.02.009_bib142","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3851\/IMP2739","article-title":"Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24\u00a0weeks post partum: results of the BAN Study","volume":"19","author":"Corbett","year":"2014","journal-title":"Antivir Ther"},{"issue":"9","key":"10.1016\/j.clp.2019.02.009_bib143","doi-asserted-by":"crossref","first-page":"e1002132","DOI":"10.1371\/journal.pmed.1002132","article-title":"Pre-exposure prophylaxis use by breastfeeding HIV-uninfected women: a prospective short-term study of antiretroviral excretion in breast milk and infant absorption","volume":"13","author":"Mugwanya","year":"2016","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.clp.2019.02.009_bib144","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/jac\/dkv435","article-title":"Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the option B-plus approach in Malawi","volume":"71","author":"Palombi","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.clp.2019.02.009_bib145","doi-asserted-by":"crossref","first-page":"e1000430","DOI":"10.1371\/journal.pmed.1000430","article-title":"HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis","volume":"8","author":"Zeh","year":"2011","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.clp.2019.02.009_bib146","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/cid\/cir008","article-title":"Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants","volume":"52","author":"Fogel","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"24","key":"10.1016\/j.clp.2019.02.009_bib147","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1056\/NEJMoa0907736","article-title":"Antiretroviral regimens in pregnancy and breast-feeding in Botswana","volume":"362","author":"Shapiro","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.clp.2019.02.009_bib148","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1097\/AOG.0000000000002662","article-title":"ACOG committee opinion no. 741. Maternal immunization","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.009_bib149","author":"Kroger"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009551081930020X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009551081930020X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:58:05Z","timestamp":1758815885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009551081930020X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":148,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S009551081930020X"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2019.02.009","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Viral Infections During Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2019.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}